NovoCure (NVCR) Interest Coverage Ratio Growth (1y) (2015 - 2022)
NovoCure (NVCR) Interest Coverage Ratio Growth (1y) (2015 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -40.19% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -12.04% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 8.92% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -54.61% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -6.18% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 66.99% |
| 10 | NovoCure | 1.63 Bn | 1.20 Bn | 135.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 27.50% |
| Mar 31, 2022 | -1,318.08% |
| Dec 31, 2021 | -390.65% |
| Sep 30, 2021 | -214.46% |
| Jun 30, 2021 | -613.34% |
| Mar 31, 2021 | 97.61% |
| Dec 31, 2020 | 4,121.37% |
| Sep 30, 2020 | 149.97% |
| Jun 30, 2020 | 163.96% |
| Mar 31, 2020 | 46.12% |
| Dec 31, 2019 | 102.19% |
| Sep 30, 2019 | 168.94% |
| Jun 30, 2019 | 138.97% |
| Mar 31, 2019 | 1.22% |
| Dec 31, 2018 | -112.22% |
| Sep 30, 2018 | 20.28% |
| Jun 30, 2018 | 65.18% |
| Mar 31, 2018 | 52.22% |
| Dec 31, 2017 | 57.44% |
| Sep 30, 2017 | 78.74% |